The outlook was revised to stable from negative.
“The outlook revision to stable reflects strong and improving financial performance at the system’s flagship MSH facility in fiscal 2016 and the current year to date,” said Martin Arrick, an S&P Global Ratings credit analyst.
The stable outlook reflects S&P’s expectation that Mount Sinai Hospital’s financial performance will continue to improve and balance sheet metrics will stabilize even though the transition risks are still eminent.
More articles on healthcare finance:
7 recent donations, grants to healthcare organizations
5 recent hospital, health system outlook and credit rating actions
5 most-read finance stories: Week of July 3-7
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
